Literature DB >> 24075746

Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients.

Michelle A H Sonneveld1, Anouk C van Dijk, Evita G van den Herik, Janine E van Loon, Lonneke M L de Lau, Aad van der Lugt, Peter J Koudstaal, Moniek P M de Maat, Frank W G Leebeek.   

Abstract

BACKGROUND: Large population studies have revealed that increased von Willebrand Factor (VWF) levels are associated with an increased risk of ischemic stroke. In previous studies VWF was associated with atherosclerosis in healthy individuals. However, it is yet unknown what the association is between atherosclerosis and VWF levels in patients with ischemic stroke.
OBJECTIVES: The aim of our study was to determine the association of atherosclerosis, measured with recent developed techniques, and VWF levels in a large, well characterized, cohort of ischemic stroke patients and to determine the prognostic value.
METHODS: We included 925 consecutive patients with transient ischemic attack (TIA) or ischemic stroke. Calcification volumes (mm(3)) were scored in the aortic arch and both carotid arteries using multidetector computed tomography (CT) angiography. VWF antigen (VWF:Ag) levels were measured using ELISA.
RESULTS: Mean VWF:Ag levels were significantly higher in the presence of calcification in either the aortic arch (1.47 vs. 1.37 IU/ml [P = 0.039]) or the carotid arteries (1.49 vs. 1.34 IU/ml [P = 0.001]). Patients with a large artery atherosclerosis ischemic stroke had significantly higher VWF:Ag levels then the other TOAST subtypes (P < 0.0001). High VWF:Ag levels were associated with an unfavorable outcome (modified Rankin Scale >2 vs. ≤2; 1.64 vs. 1.41 IU/ml, [P < 0.0001]).
CONCLUSION: Our study showed a strong association between the extent of atherosclerosis in both the aortic arch and the carotid arteries and VWF levels in patients with TIA or ischemic stroke. Higher VWF levels are found in large artery atherosclerosis and are associated with a poor outcome.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ischemic stroke; Transient ischemic attack; Vascular calcification; Von Willebrand Factor

Mesh:

Substances:

Year:  2013        PMID: 24075746     DOI: 10.1016/j.atherosclerosis.2013.07.046

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Clinical role of von Willebrand factor in acute ischemic stroke.

Authors:  Marija Menih; Miljenko Križmarić; Tanja Hojs Fabjan
Journal:  Wien Klin Wochenschr       Date:  2017-04-13       Impact factor: 1.704

2.  Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.

Authors:  W O Tobin; J A Kinsella; G F Kavanagh; J S O'Donnell; R T McGrath; T Coughlan; D R Collins; D O'Neill; B Egan; S Tierney; T M Feeley; R P Murphy; D J H McCabe
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

3.  Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study.

Authors:  Hugo J Aparicio; Rodica E Petrea; Joseph M Massaro; Warren J Manning; Noriko Oyama-Manabe; Alexa S Beiser; Carlos S Kase; Ralph B D'Agostino; Philip A Wolf; Ramachandran S Vasan; Charles DeCarli; Christopher J O'Donnell; Sudha Seshadri
Journal:  Atherosclerosis       Date:  2017-06-23       Impact factor: 5.162

4.  The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction.

Authors:  Shu-Jin Wang; Zhong-Sen Qu; Qing-De Zhang; Liang Li; Feng Wang; Bin Zhang; Bang-Li Wu; Yu-Wu Zhao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  The Role of Hemostatic Factors in Atherosclerosis in Patients with Chronic Renal Disease.

Authors:  Manal Zahran; Fatma Mohammed Nasr; Amna Ahmed Metwaly; Noha El-Sheikh; Nevine Sherif Ali Khalil; Tarek Harba
Journal:  Electron Physician       Date:  2015-09-16

6.  Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins.

Authors:  Yuta Kato; Atsushi Iwata; Makito Futami; Motoki Yamashita; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 7.  Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence.

Authors:  Nina Buchtele; Michael Schwameis; James C Gilbert; Christian Schörgenhofer; Bernd Jilma
Journal:  Thromb Haemost       Date:  2018-05-30       Impact factor: 5.249

8.  von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.

Authors:  Stephen J X Murphy; Soon Tjin Lim; Fionnuala Hickey; Justin A Kinsella; Deirdre R Smith; Sean Tierney; Bridget Egan; T Martin Feeley; Sinéad M Murphy; D Rónán Collins; Tara Coughlan; Desmond O'Neill; Joseph A Harbison; Prakash Madhavan; Sean M O'Neill; Mary-Paula Colgan; James S O'Donnell; Jamie M O'Sullivan; George Hamilton; Dominick J H McCabe
Journal:  Thromb Haemost       Date:  2020-09-15       Impact factor: 5.249

9.  Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke.

Authors:  Samantha J Donkel; Boutaina Benaddi; Diederik W J Dippel; Hugo Ten Cate; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

Review 10.  ADAMTS-13 and von Willebrand factor: a dynamic duo.

Authors:  K South; D A Lane
Journal:  J Thromb Haemost       Date:  2017-12-02       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.